Acadia Healthcare Company, Inc.
General ticker "ACHC" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $1.9B (TTM average)
Acadia Healthcare Company, Inc. follows the US Stock Market performance with the rate: 31.9%.
Estimated limits based on current volatility of 5.5%: low 27.57$, high 30.81$
Factors to consider:
- Total employees count: 25000 (-2.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Litigation risks, Liquidity and credit risks, Patient care incidents, Cybersecurity threats
- Current price 41.5% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.74$, 20.94$]
- 2026-12-31 to 2027-12-31 estimated range: [9.42$, 21.41$]
Financial Metrics affecting the ACHC estimates:
- Positive: with PPE of 7.1 at the end of fiscal year the price was low
- Positive: 7.78 < Operating profit margin, % of 11.71
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 6.73 < Operating cash flow per share per price, % of 10.09
- Negative: Industry operating profit margin (median), % of -0.34 <= 2.95
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.54
Short-term ACHC quotes
Long-term ACHC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,928.74MM | $3,153.96MM | $3,312.77MM |
| Operating Expenses | $2,954.10MM | $2,631.69MM | $2,924.80MM |
| Operating Income | $-25.36MM | $522.28MM | $387.96MM |
| Non-Operating Income | $0.00MM | $-180.40MM | $-1,453.91MM |
| Interest Expense | $82.12MM | $116.37MM | $138.86MM |
| Income(Loss) | $-25.36MM | $341.88MM | $-1,065.94MM |
| Taxes | $-9.70MM | $77.39MM | $25.98MM |
| Net Income(Loss)* | $-21.67MM | $255.61MM | $-1,102.77MM |
| Stockholders Equity | $2,781.97MM | $3,073.72MM | $1,948.96MM |
| Inventory | $5.30MM | $5.65MM | $5.69MM |
| Assets | $5,358.84MM | $5,956.91MM | $5,527.45MM |
| Operating Cash Flow | $462.34MM | $129.69MM | $131.90MM |
| Capital expenditure | $424.13MM | $690.38MM | $571.81MM |
| Investing Cash Flow | $-397.22MM | $-736.48MM | $-556.21MM |
| Financing Cash Flow | $-62.70MM | $583.02MM | $481.25MM |
| Earnings Per Share** | $-0.24 | $2.79 | $-12.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.